0 165

Cited 2 times in

Prognostic significance of three endothelial nitric oxide synthase (eNOS) polymorphisms and metabolic syndrome (MetS) in patients with colorectal cancer

DC Field Value Language
dc.contributor.author오지수-
dc.date.accessioned2022-12-22T02:22:58Z-
dc.date.available2022-12-22T02:22:58Z-
dc.date.issued2022-06-
dc.identifier.issn1976-9571-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/191555-
dc.description.abstractBackground: Polymorphisms of endothelial nitric oxide synthases (eNOS) have been associated with cancer susceptibility. Also, metabolic syndrome is associated with cancer malignancy. However, the effect of eNOS polymorphisms and metabolic syndrome on colorectal cancer (CRC) prognosis remains unclear. Objective: To investigated whether three genetic polymorphisms (- 786 T > C rs2070744, 4a4b rs869109213, and 894G > T rs1799983) in the eNOS and metabolic syndrome (MetS) were associated with CRC patient survival. Methods: We genotyped three polymorphisms of eNOS (- 786 T > C, 4a4b, and 894G > T) in 312 CRC cases from the Korean population by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. Results: Although the three eNOS polymorphisms were not causative of MetS, the TT genotype of the 894G > T polymorphism was associated with a worse survival rate compared with the GG genotype in the CRC group with MetS than in the CRC group without MetS (5-years survival; adjusted HR = 54.777; 95% CI 5.073-591.487 and RFS; adjusted HR = 14.909; 95% CI 1.571-141.528). Conclusions: The eNOS polymorphisms were not associated with metabolic syndrome prevalence in CRC patients. However, our findings suggest that the eNOS 894G > T polymorphism with MetS was associated with poor clinical outcomes.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherGenetics Society of Korea-
dc.relation.isPartOfGENES & GENOMICS-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHColorectal Neoplasms* / complications-
dc.subject.MESHColorectal Neoplasms* / genetics-
dc.subject.MESHHumans-
dc.subject.MESHMetabolic Syndrome* / complications-
dc.subject.MESHMetabolic Syndrome* / genetics-
dc.subject.MESHNitric Oxide Synthase Type III / genetics-
dc.subject.MESHPolymorphism, Genetic-
dc.subject.MESHPrognosis-
dc.titlePrognostic significance of three endothelial nitric oxide synthase (eNOS) polymorphisms and metabolic syndrome (MetS) in patients with colorectal cancer-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorEun Ju Ko-
dc.contributor.googleauthorEo Jin Kim-
dc.contributor.googleauthorHye Jung Cho-
dc.contributor.googleauthorJisu Oh-
dc.contributor.googleauthorHan Sung Park-
dc.contributor.googleauthorChang Soo Ryu-
dc.contributor.googleauthorJung Oh Kim-
dc.contributor.googleauthorHak Hoon Jun-
dc.contributor.googleauthorSo Young Chong-
dc.contributor.googleauthorJong Woo Kim-
dc.contributor.googleauthorNam Keun Kim-
dc.identifier.doi10.1007/s13258-022-01246-9-
dc.contributor.localIdA06131-
dc.relation.journalcodeJ00928-
dc.identifier.eissn2092-9293-
dc.identifier.pmid35377131-
dc.identifier.urlhttps://link.springer.com/article/10.1007/s13258-022-01246-9-
dc.subject.keywordColorectal cancer-
dc.subject.keywordMetabolic syndrome-
dc.subject.keywordNitric oxide-
dc.subject.keywordPolymorphism-
dc.subject.keywordSusceptibility-
dc.subject.keywordeNOS-
dc.contributor.alternativeNameOh, Jisu-
dc.contributor.affiliatedAuthor오지수-
dc.citation.volume44-
dc.citation.number6-
dc.citation.startPage659-
dc.citation.endPage670-
dc.identifier.bibliographicCitationGENES & GENOMICS, Vol.44(6) : 659-670, 2022-06-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.